Stocks
Intra-Cellular Therapies (ITCI) OCF US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| OCF, bln rub | ? | -230.1 | -259.5 | -270.2 | -124.2 | -73.2 | -73.2 | ||
| Changes by years, y/y, % | +80% | +13% | +4% | -54% | -41% | -10.6% | |||
Intra-Cellular Therapies. OCF, bln rub
Intra-Cellular Therapies. OCF, changes, %
Intra-Cellular Therapies. OCF, sum by quarters, bln rub
Intra-Cellular Therapies (ITCI) OCF US GAAP (quarter values) |
||||||||
| FY2023Q4 | FY2024Q1 | FY2024Q2 | FY2024Q3 | FY2024Q4 | LTM ? | |||
| OCF, bln rub | ? | -2.06 | -34.1 | 0.542 | -26.5 | -13.1 | -73.2 | |
| Changes by years, y/y, % | -95% | -43% | -101% | +5% | +535% | |||
| Changes by quarters, q/q, % | -92% | +1 555% | -102% | -4 994% | -51% | |||
